Searchable abstracts of presentations at key conferences in endocrinology

ea0032p274 | Clinical case reports - Thyroid / Others | ECE2013

Paraganglioma, germline nonsense mutation in succinate dehydrogenase B gene (R27X) and response to sunitinib

Elezovic Valentina , Petakov Milan , Ognjanovic Sanja , Macut Djuro , Isailovic Tatjana , Ilic Bojana , Popovic Bojana , Antic Ivana Bozic , Bogavac Tamara , Ilic Dusan , Damjanovic Svetozar

A 36-years-old male with mild hypertension was diagnosed with pseudocystic tumor (67 mm) in pancreatic region and liver metastasis in April 2010. One month later, the extirpation of retroperitoneal mass and metastasis was performed in local medical centre. Pathohistological diagnosis was metastatic paraganglioma (Ki67, 3.5%). In June 2010, he was transferred to our Institution, and (131) I-metaiodobenzylguanidine (MIBG) scintigraphy was negative. However ((18) F) fluorodeoxygl...

ea0032p531 | Endocrine tumours and neoplasia | ECE2013

Long-term outcome after transarterial chemoembolization of hepatic metastases from neuroendocrine tumors

Ognjanovic Sanja , Petakov Milan , Isailovic Tatjana , Elezovic Valentina , Macut Djuro , Popovic Bojana , Bozic Ivana , Bogavac Tamara , Ilic Dusan , Colic Momcilo , Damjanovic Svetozar

Introduction: Most patients with neuroendocrine tumors (NETs) present with liver involvement at the time of diagnosis. Trans-catheter arterial chemoembolization (TACE) is accepted treatment of patients with non-resectable hepatic metastases from NETs.Aim: To analyze objective tumor response and clinical outcome in patients with hepatic metastases from NETs who underwent TACE.Methods: Thirty-one patients underwent 140 TACE procedure...

ea0032p535 | Endocrine tumours and neoplasia | ECE2013

Adrenal lesions in patients with neuroendocrine tumors

Popovic Bojana , Macut Djuro , Petakov Milan , Bozic Ivana , Bogavac Tamara , Isailovic Tatjana , Ognjanovic Sanja , Elezovic Valentina , Micev Marjan , Menkovic Nemanja , Ilic Dusan , Damjanovic Svetozar

Introduction: The coexistence of adrenal tumors (AT) in patients with neuroendocrine tumors (NETs) has not been extensively studied. The aim of our study was to investigate their prevalence and clinical significance in these patients.Materials and methods: We retrospectively studied 447 patients with NETs of all localizations, treated at our department between 2004 and 2012. Diagnosis was established pathohistologically, classification performed accordin...

ea0032p587 | Female reproduction | ECE2013

The hypothalamo--pituitary--adrenal axis sensitivity in women with polycystic ovary syndrome

Ilic Dusan , Macut Djuro , Bozic Antic Ivana , Bjekic-Macut Jelica , Milutinovic Danijela Vojnovic , Petakov Milan , Popovic Bojana , Ognjanovic Sanja , Bogavac Tamara , Isailovic Tatjana , Elezovic Valentina , Damjanovic Svetozar

Introduction: It has been shown that most women with polycystic ovary syndrome (PCOS) have increased adrenal androgen production, enhanced peripheral metabolism of cortisol and elevated in urinary excretion of its metabolites. Simultaneously, this increased cortisol clearance in PCOS was shown to be followed by a compensatory overdrive of the hypothalamo–pituitary–adrenal (HPA) axis. The aim of this study was to determine HPA axis sensitivity in women woth PCOS.<...

ea0032p602 | Female reproduction | ECE2013

Relation of adiponectin and leptin to antropometric and metabolic parameteres in women with polycystic ovaries syndrome

Bogavac Tamara , Macut Djuro , Bozic Antic Ivana , Bjekic-Macut Jelica , Vojnovic Milutinovic Danijela , Petakov Milan , Popovic Bojana , Ognjanovic Sanja , Isailovic Tatjana , Elezovic Valentina , Ilic Dusan , Damjanovic Svetozar

Introduction: Women with polycystic ovary syndrome (PCOS) are characterized with insulin resistance and hyperinsulinaemia. Adiponectin and leptin are adipose tissue-specific products and are correlated with insulin resistance. The aim of the study was to access the relation of adiponectin with anthropometric, metabolic and hormonal parameters in a group of women with PCOS.Methods: We studied 57 non-obese women with PCOS diagnosed using ESHRE/ASRM criteri...

ea0032p893 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Myeloproliferative neoplasms in patients with acromegaly

Isailovic Tatjana , Beleslin Bojana , Lalic Nebojsa , Lukic Ljiljana , Popovic Bojana , Petakov Milan , Macut Djuro , Ognjanovic Sanja , Elezovic Valentina , Bozic Ivana , Bogavac Tamara , Ilic Dusan , Pekmezovic Tatjana , Damjanovic Svetozar

Introduction: Generously supported by IPSEN)-->The coexistence of acromegaly and secondary polycythemia has been described in a few patients. This association was ascribed to GH/IGF1 proliferative effect on bone marrow progenitor cells. In contrast, the presence of myeloproliferative neoplasm (MPN) with documented JAK2 mutation so far has been described in only one acromegalic patient.Methods: We analyzed the p...

ea0056gp137 | Female Reproduction | ECE2018

Hypothalamo-pituitary-adrenal axis sensitivity in women with polycystic ovary syndrome

Macut Djuro , Bozic-Antic Ivana , Ilic Dusan , Bogavac Tamara , Bjekic-Macut Jelica , Vojnovic-Milutinovic Danijela , Stanojlovic Olivera , Popovic Bojana , Isailovic Tatjana , Elezovic-Kovacevic Valentina , Ognjanovic Sanja

Introduction: Hypothalamo-pituitary-adrenal (HPA) axis dysregulation could be a link between polycystic ovary syndrome (PCOS) and cardiometabolic and psychological complications associated with disease.Methods: We analyzed 50 women with PCOS according to ESHRE/ASRM criteria [age 28.66±5.61, body mass index (BMI) 21.94±3.38 kg/m2] and 50 BMI- and age-matched healthy women (control group, CG), (age 28.66±5.63, BMI 22.09±3.70 ...

ea0056p68 | Adrenal cortex (to include Cushing's) | ECE2018

Association of the BclI glucocorticoid receptor polymorphism with metabolic parameters in female patients with adrenal incidentalomas

Ognjanovic Sanja , Antic Jadranka , Macut Djuro , Kovacevic Valentina Elezovic , Isailovic Tatjana , Popovic Bojana , Antic Ivana Bozic , Bogavac Tamara , Ilic Dusan , Petakov Milan , Damjanovic Svetozar

Interindividual variations in tissue sensitivity to glucocorticoids have been partly attributed to polymorphisms in the glucocorticoid receptor (GR) gene. The aim of this study was to investigate the prevalence of subclinical hypercortisolism (SH) in women with adrenal incidentaloma (AI), and whether BclI variant of the GR gene may contribute to metabolic abnormalities frequently present in these patients. We evaluated 106 women with AI. Anthropometric characteristics...

ea0056p717 | Clinical case reports - Pituitary/Adrenal | ECE2018

Cushing’s disease, bilateral adrenal hyperplasia and ARMC5 mutation – case report

Elezovic Kovacevic Valentina , Macut Djuro , Antic Jadranka , Ognjanovic Sanja , Isailovic Tatjana , Popovic Bojana , Bozic-Antic Ivana , Bogavac Tamara , Ilic Dusan , Damjanovic Svetozar

Germline ARMC5 mutations have been described as the most frequent genetic abnormality found in patients diagnosed with primary bilateral macronodular adrenal hyperplasia (PBMAH). PBMAH is a rare etiology of Cushing’s syndrome. This gene has been proposed to acts as a tumor-suppressor gene. A 36-years old female presented to us with clinical signs of hypercortisolism. ACTH dependent Cushing’s syndrome was confirmed soon after. Pituitary magnetic resonance imaging (MRI...

ea0056p890 | Bone ' Osteoporosis | ECE2018

Bone mineral density in oligomenorrhoeic women with polycystic ovary syndrome

Ilic Dusan , Bozic-Antic Ivana , Bogavac Tamara , Bjekic-Macut Jelica , Vojnovic-Milutinovic Danijela , Stanojlovic Olivera , Popovic Bojana , Isailovic Tatjana , Elezovic-Kovacevic Valentina , Ognjanovic Sanja , Macut Djuro

Introduction: Oligomenorrhoea have negative impact on bone mineral density (BMD). The aim of this study was to analyze BMD in oligomenorrhoeic women with polycystic ovary syndrome (PCOS), and healthy controls with regular menstrual cycles.Methods: We analyzed 29 women with PCOS diagnosed using ESHRE/ASRM criteria (age: 23.6±4.7 years, BMI: 24.9±6.1 kg/m2) and 22 healthy BMI-matched controls (HC) (age 31.6±6.3 years, BMI 24.9&#17...